MediciNova to Receive $2.5 Million Payment From Kissei Pharmaceutical Co. Ltd … – MarketWatch (press release)

MediciNova to Receive $2.5 Million Payment From Kissei Pharmaceutical Co. Ltd
MarketWatch (press release)
Ltd., a pharmaceutical company traded on the Tokyo Stock Exchange (4547), will pay MediciNova $2.5 million, within 30 days, to support further clinical development of MN-221 for the treatment of acute exacerbations of asthma or chronic obstructive

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.